Evidence map›Paper›PMID 40234749›Full record

SynthesisBMC infectious diseases2025

A systematic review and meta-analysis of antibiotic resistance of foodborne pathogenic bacteria.

Aron Rezene Mebrahtu, Likulunga Emmanuel Likulunga, Adriace Chauwa, Mildred Zulu, Sydney Malama

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aron Rezene MebrahtuBiosciences and Biotechnology Department, School of Natural and Applied Sciences, University of Zambia, Lusaka, Zambia.
Likulunga Emmanuel LikulungaBiosciences and Biotechnology Department, School of Natural and Applied Sciences, University of Zambia, Lusaka, Zambia.
Adriace ChauwaEnteric Disease and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Mildred ZuluDepartmrnt of Pathology and Microbiology, School of Medicine, University of Zambia, Lusaka, Zambia.
Sydney MalamaBiosciences and Biotechnology Department, School of Natural and Applied Sciences, University of Zambia, Lusaka, Zambia. sydneymalama1971@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial drugs are used to treat bacterial pathogens that cause infections in humans and animals. Despite their importance, antimicrobial drugs exhibit inefficiency in treating infections if used irrationally without adherence to standard guidelines. Currently there is a lack of review literatures concerning antimicrobial resistance status in the southern sub Saharan African countries, hence the study is designed for and provides valuable insights into the status and comparison of antimicrobial resistance among foodborne bacteria in Zambia relative to other regions of the world, using systematic literature review and meta-analysis. For meta-analysis of bacterial and AMR prevalence and, generation of forest plots, functions from R packages were used and meta-regression analysis using the random effect model with the R functions "escalc" and "rma" from R "metafor" package was used to determine sample size on bacterial prevalence. A total of 434 articles were identified and downloaded after a systematic research. The study has implicated that the most common foodborne bacteria in the last five years in Zambia are salmonella spp., E. coli., and L. monocytogens. Based on the random effect model, the prevalence of bacterial pathogens across all studies in food samples was observed to be 11% and in human samples was 14%. The study found a significant increase in antimicrobial resistance (AMR) burden among foodborne pathogens in Zambia compared to other regions of the world over the past five years. This rise is attributed to the bacteria's ability to develop resistance mechanisms and easily spread between humans, animals, and the environment. Ineffective surveillance, inadequate management by stakeholders, and public unawareness have further exacerbated the problem, requiring effective policy implementations in the health sector.

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, BacterialFoodborne DiseasesFood MicrobiologyAnimalsHumansPrevalenceZambiaAnti-Bacterial AgentsAntimicrobial drugsAntimicrobial resistanceFoodborne bacteriaMeta-analysis

Identifiers

PMID40234749
PMCPMC12001587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.